Effect of lipid nanoparticles containing fatty alcohols having different chain length on the ex vivo skin permeability of Econazole nitrate

Powder Technology

Volumn 201, Issue 1, 2010, Pages 32-36

  Sanna, Vanna ^a   Caria, Giuseppe ^b   Mariani, Alberto ^b  

^a Prion DGN c/o Porto Conte Ricerche   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

Fatty alcohols; Lipid nanoparticles; Skin permeation

Indexed keywords

ALCOHOL CHAIN LENGTH; CRYSTALLINE STRUCTURE; DRUG PERMEATION; ENCAPSULATION EFFICIENCY; EX-VIVO; FATTY ALCOHOLS; HIGH SHEAR; LIPID NANOPARTICLES; LIPID PHASE; MEAN DIAMETER; PERMEABILITY COEFFICIENTS; SKIN PERMEABILITY; SKIN PERMEATION;

CAPILLARITY; CHAIN LENGTH; CONTROLLED DRUG DELIVERY; DRUG INTERACTIONS; ENCAPSULATION; NANOPARTICLES; STATISTICAL TESTS;

ALCOHOLS;

ECONAZOLE; FATTY ALCOHOL; GLYCEROL PALMITOSTEARATE; LIPID; NANOPARTICLE; SKIN LIPID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG PENETRATION; DRUG STRUCTURE; DRUG TRANSPORT; ENCAPSULATION; EX VIVO STUDY; HYDROGEL; NONHUMAN; PARTICLE SIZE; SKIN PERMEABILITY; STRATUM CORNEUM; SWINE;

EID: 77952290634     PISSN: 00325910     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.powtec.2010.02.035     Document Type: Article

References (30)

1. Yamashita F., Hashida M. Mechanistic and empirical modelling of skin permeation of drugs. Adv. Drug Deliv. Rev. 2003, 55:1185-1199.
2. Barry B.W. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 2001, 14:101-114.
3. Benson H.A.E. Transdermal drug delivery: penetration enhancement techniques. Curr. Drug Deliv. 2005, 2:23-33.
4. Schäfer-Korting M., Mehnert W., Korting H.C. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 2007, 59:427-443.
5. El-Kattan A.F., Asbill C.S., Michniak B.B. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int. J. Pharm. 2000, 198:179-189.
6. Muller R.H., Radtke M., Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 2002, 54:S131-S155.
7. Wissing S., Muller R.H., Manthei L., Mayer C. Structural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopy. Pharm. Res. 2004, 21:400-405.
8. Maia C.S., Mehnert W., Schafer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int. J. Pharm. 2000, 196:165-167.
9. Zhai H., Maibach H.I. Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol. Appl. Skin Physiol. 2001, 14:1-10.
10. Muller R.H., Radtke M., Wissing S.A. Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 2002, 242:121-128.
11. Souto E.B., Wissing S.A., Barbosa C.M., Muller R.H. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm. 2004, 278:71-77.
12. Sanna V., Gavini E., Cossu M., Rassu G., Giunchedi P. Solid Lipid Nanoparticles (SLN) as carriers for the topical delivery of Econazole nitrate: in vitro characterization, ex-vivo and in-vivo studies. J. Pharm. Pharmacol. 2007, 59:1057-1064.
13. Sanna V., Mariani A., Caria G., Sechi M. Synthesis and evaluation of different fatty acid esters formulated into Precirol® ATO-based lipid nanoparticles as vehicles for topical delivery. Chem. Pharm. Bull. 2009, 57:680-684.
14. Lombardi Borgia S., Regehly M., Sivaramakrishnan R., Mehnert W., Korting H.C., Danker K., Röder B., Kramer K.D., Schäfer-Korting M. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J. Control. Release 2005, 110:151-163.
15. Fujii M., Hori N., Shiozawa K., Wakabayashi K., Kawahara E., Matsumoto M. Effect of fatty acid Esters on permeation of ketoprofen through hairless rat skin. Int. J. Pharm. 2000, 205:117-125.
16. Trommer H., Neubert R.H. Overcoming the stratum corneum: the modulation of skin penetration. Skin Pharmacol. Physiol. 2006, 19:106-121.
17. Gavini E., Rassu G., Sanna V., Cossu M., Giunchedi P. Mucoadhesive microspheres for nasal administration of an antiemetic drug, Metoclopramide: in vitro/ex vivo studies. J. Pharm. Pharmacol. 2005, 57:287-294.
18. Passerini N., Gavini E., Albertini B., Rassu G., Di Sabatino M., Sanna V., Giunchedi P., Rodriguez L. Evaluation of solid lipid microparticles produced by spray congealing for Econazole Nitrate topical application. J. Pharm. Pharmacol. 2009, 61:559-567.
19. Sanna V., Kirschvink N., Gustin P., Gavini E., Roland I., Delattre L., Evrard B. Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSciTech 2004, 5. art. 27.
20. Vaddi H.K., Ho P.C., Chan Y.W., Cha S.W. Terpenes in ethanol: haloperidol permeation and partition through human skin and stratum corneum change. J. Control. Release 2002, 8:121-133.
21. Donini C., Robinson D.N., Colombo P., Giordano F., Peppas N.A. Preparation of poly(methacrylic acid-g-poly(ethylene glycol)) nanospheres from methacrylic monomers for pharmaceutical applications. Int. J. Pharm. 2002, 245:83-91.
22. Souto E.B., Wissing S.A., Barbosa C.M., Muller R.H. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur. J. Pharm. Biopharm. 2004, 58:83-90.
23. Jenning V., Thunemann A.F., Gohla S.H. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int. J. Pharm. 2000, 199:167-177.
24. Hu F.Q., Jiang S.P., Du Y.Z., Yuan H., Ye Y.Q., Zeng S. Preparation and characteristics of monostearin nanostructured lipid carriers. Int. J. Pharm. 2006, 314:83-89.
25. Bunjes H., Koch M.H.J., Westesen K. Effect of particle size on colloidal solid triglycerides. Langmuir 2000, 16:5234-5241.
26. Andega S., Kanikkannan N., Singh M. Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J. Control. Release 2001, 77:17-25.
27. Lee C., Uchida T., Noguchi E., Kim N., Goto S. Skin permeation enhancement of Tegafur by ethanol-panasate 800 or ethanol-water bynary vehicle and combined effect of fatty acids and fatty alcohol. J. Pharm. Sci. 1993, 82:1155-1159.
28. Sloan K.B., Beall H.D., Taylor H.E. Transdermal delivery of theophilline from alcohol vehicles. Int. J. Pharm. 1998, 171:185-193.
29. Aungst B., Rogers N., Shefter E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactant, sulfoxides, and amides. Int. J. Pharm. 1986, 33:225-234.
30. Kanikkannan N., Kandimalla K., Lamba S.S., Singh M. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr. Med. Chem. 1999, 6:593-608.